Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.

Campbell’s Company (NASDAQ: CPB) released its third-quarter fiscal 2025 results, showcasing a solid performance with notable ...

SAIC's first-quarter revenues grew by 2% to $1.88 billion, surpassing expectations. However, its earnings per share fell ...

Moderna stock jumped 4.93% to $27.87 in premarket trading after the FDA granted limited approval for mNEXSPIKE, a new COVID-19 vaccine requiring only one-fifth the dose of the company's current ...